Uncover key drivers, emerging technologies, and competitive movements shaping the worker heat stress monitoring wearable market from 2026–2035 with trusted insights from The Business Research Company
What total market size is anticipated for the Infectious Disease Diagnostics Testing Market in 2030?
The infectious disease diagnostics testing market size has undergone rapid expansion in recent years. Projections indicate it will grow from $42.24 billion in 2025 to $46.48 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 10.0%. The growth observed in the past period is attributable to the increasing prevalence of infectious diseases, a rising incidence of respiratory infections, the expansion of diagnostic laboratory infrastructure, growing awareness about early disease diagnosis, and an increased governmental focus on disease control.
The infectious disease diagnostics testing market is anticipated to experience substantial growth over the coming years. It is projected to reach $65.49 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 9.0%. This expansion during the forecast period is primarily driven by factors such as the increasing global pandemic risk, a heightened need for swift diagnostic solutions, greater financial commitments in healthcare diagnostics, the broadening scope of disease surveillance initiatives, and the escalating prevalence of tropical and viral diseases. Key developments expected within this period include a surging demand for prompt and early detection of infectious diseases, the increasing uptake of point-of-care tests for infectious conditions, a greater reliance on molecular diagnostics for identifying pathogens, the broadening of diagnostic testing efforts for both emerging and re-emerging infections, and an enhanced focus on extensive disease screening and surveillance activities.
Access Your Free Sample Report for In-Depth Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15831&type=smp
What Drivers Are Influencing Production Trends In The Infectious Disease Diagnostics Testing Market?
The anticipated increase in respiratory infections is projected to fuel the expansion of the infectious disease diagnostic testing market moving forward. These infections target the respiratory system, encompassing the nose, throat, airways, and lungs. The surge in respiratory infections stems from viral and bacterial spread via close interaction with infected persons, inadequate hygiene, cramped living environments, and cyclical weather changes. Accurate identification of pathogens like bacteria and viruses in patient specimens makes infectious disease diagnostic testing crucial for the diagnosis and management of respiratory infections. As an illustration, figures from February 2024, released by the Canadian Institute for Health Information, a Canada-based non-profit organization, revealed a 32% rise in hospital admissions for acute upper respiratory infections, climbing from 2,114 in 2022 to 2,797 cases in 2023. Consequently, the uptick in respiratory infections is stimulating the infectious disease diagnostic testing market.
Which Segments Are Gaining Traction In The Infectious Disease Diagnostics Testing Market?
The infectious disease diagnostics testing market covered in this report is segmented –
1) By Type: Molecular Diagnostic Test, Point Of Care Tests (POCT) Infectious Disease Diagnostics Test
2) By Application: Respiratory, Human Immunodeficiency Virus (HIV), Healthcare-Associated Infections (HAIs), Sexual Health, Tropical Diseases
3) By End-User: Diagnostic Laboratories, Hospitals And Clinics
Subsegments:
1) By Molecular Diagnostic Test: Polymerase Chain Reaction (PCR) Tests, Nucleic Acid Amplification Tests (NAATs)
2) By Point Of Care Tests (POCT) Infectious Disease Diagnostics Test: Lateral Flow Assays, Rapid Antigen Tests, Immunoassays, Portable PCR
Which Competitive Trends Are Impacting The Structure Of The Infectious Disease Diagnostics Testing Market?
Leading companies in the infectious disease diagnostic testing market are developing advanced technologies for the swift and reliable identification of critical infections. Infectious disease diagnostics involves the detection of pathogens, such as bacteria, viruses, or parasites, to guide both diagnosis and subsequent treatment. For example, in January 2025, QIAGEN, a German biotechnology company, introduced new QIAstat-Dx syndromic testing panels in India. These included the Gastrointestinal Panel 2 and Meningitis/Encephalitis Panel, offered alongside the previously authorized Respiratory SARS-CoV-2 Panel, all of which received approval from India’s Central Drugs Standard Control Organization (CDSCO). The QIAstat-Dx system leverages multiplex real-time PCR with single-use cartridges to simultaneously detect multiple pathogens, yielding results in approximately one hour for gastrointestinal infections and 80 minutes for central nervous system infections. These panels significantly improve diagnostic speed and accuracy compared to conventional methods, thereby enabling timely treatment, enhancing patient outcomes, and reducing the strain on healthcare systems. The system additionally features configurable setups and cloud connectivity, facilitating remote monitoring and efficient data management.
Who Are The Primary Competitors In The Global Infectious Disease Diagnostics Testing Market?
Major companies operating in the infectious disease diagnostics testing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Becton Dickinson And Company, Quest Diagnostics Incorporated, Grifols S.A., Hologic Inc., PerkinElmer Inc., bioMérieux SA, Quidel Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., DiaSorin SpA (Luminex), Seegene Inc., Ortho Clinical Diagnostics Inc., OraSure Technologies Inc., Meridian Bioscience Inc., Trinity Biotech PLC
Access The Complete Report For Deeper Market Insights:
Which Regions Are Projected To Dominate The Infectious Disease Diagnostics Testing Market In The Coming Years?
North America was the largest region in the infectious disease diagnostics testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the infectious disease diagnostics testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request Your Customized Infectious Disease Diagnostics Testing Market Research Report for Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=15831&type=smp
Browse Through More Reports Similar to the Global Infectious Disease Diagnostics Testing Market 2026, By The Business Research Company
Disposable Incontinence Products Global Market Report 2026
Urinary Incontinence Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/urinary-incontinence-global-market-report
Urinary Incontinence And Pelvic Organ Prolapse Devices And Equipment Global Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company